60 Stocks Moving In Thursday s Mid-Day Session Benzinga 12/10/2020
Gainers
Immutep Limited (NASDAQ: IMMP) shares jumped 198.6% to $6.42 after the company said its Chinese partner, EOC Pharma will commence a new Phase 2 clinical trial of Immutep s eftilagimod alpha in up to 152 metastatic breast cancer patients in China. Immutep said the study follows encouraging data reported by it in its APIAC Phase 2b study announced at the end of March and presented at the SABCS.
Greenwich LifeSciences, Inc. (NASDAQ: GLSI) shares surged 67.4% to $95.60. Greenwich LifeSciences shares jumped 998% on Wednesday after the company shared the poster for the GP2 Phase 2b clinical trial final efficacy analysis that was presented Wednesday at the 2020 San Antonio Breast Cancer Symposium.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The market was valued at US$306 million in 2019 and is projected to reach US$807 million by 2027. It is expected to grow at a CAGR of 13.2% during the forecast period. The report highlights key factors driving the market growth, and prominent players and their developments in the market.
With widespread outbreaks of viruses, ransomware, and other malicious software throughout the internet, different alternatives for securing corporate networks are used. One of these methods is data diode, also known as unidirectional network.Data diodes are fool proof ways to safeguard confidential data and sensitive systems. Data diodes are small hardware devices that sit between two networks, i. e. source and destination to ensure one-way communication. The data diode is a cybersecurity solution that protects unidirectional information exchange. The high assurance hardware device keeps network integrity by preventing ma